Discharge Disposition After Head and Neck Reconstruction: Effect on Adjuvant Therapy and Outcomes

Laryngoscope. 2023 Nov;133(11):2977-2983. doi: 10.1002/lary.30648. Epub 2023 Mar 10.

Abstract

Objectives: Head and neck cancer patients that require major reconstruction often have advanced-stage disease. Discharge disposition of patients can vary and impact time to adjuvant treatment. We sought to examine outcomes in patients discharged to skilled nursing facilities (SNF) compared to those discharged home, including the impact on adjuvant therapy initiation and treatment package time (TPT).

Methods: Patients with head and neck squamous cell carcinoma treated with surgical resection and microvascular free flap reconstruction from 2019 to 2022 were included. Retrospective review was conducted to evaluate the impact of disposition on time to radiation (RT) and TPT.

Results: 230 patients were included, with 165 (71.7%) discharged to home and 65 (28.3%) discharged to SNF. 79.1% of patients were recommended adjuvant therapy. Average time to RT was 59 days for patients discharged to home compared to 70.1 days for patients discharged to SNF. Disposition was an independent risk factor for delays to starting RT (p = 0.03). TPT was 101.7 days for patients discharged to home versus 112.3 days for those who discharged to SNF. Patients discharged to SNF had higher rates of readmission (p < 0.005) compared to patients discharged home in an adjusted multivariate logistic regression.

Conclusions: Patients discharged to an SNF had significantly delayed time to initiation of adjuvant treatment and higher rates of readmission. Timeliness to adjuvant treatment has recently been established as a quality measure, thus identifying delays to adjuvant treatment initiation should be a priority.

Level of evidence: 3 Laryngoscope, 133:2977-2983, 2023.

Keywords: adjuvant therapy; disposition; head and neck; microvascular free flap; radiation therapy; readmission; reconstruction; skilled nursing facility; treatment package time.

MeSH terms

  • Head and Neck Neoplasms* / surgery
  • Humans
  • Patient Discharge*
  • Patient Readmission
  • Retrospective Studies
  • Risk Factors
  • Skilled Nursing Facilities